vs
Side-by-side financial comparison of GE HealthCare (GEHC) and McDonald's (MCD). Click either name above to swap in a different company.
McDonald's is the larger business by last-quarter revenue ($7.0B vs $5.1B, roughly 1.4× GE HealthCare). McDonald's runs the higher net margin — 30.9% vs 8.0%, a 22.9% gap on every dollar of revenue. On growth, McDonald's posted the faster year-over-year revenue change (9.7% vs 7.4%). McDonald's produced more free cash flow last quarter ($1.6B vs $112.0M). Over the past eight quarters, McDonald's's revenue compounded faster (6.6% CAGR vs 3.0%).
GE Healthcare Technologies, Inc., stylized GE HealthCare, is an American health technology company based in Chicago, Illinois. It operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures...
McDonald's Corporation, doing business as McDonald's, is an American multinational fast food restaurant chain. As of 2024, it is the second-largest by number of locations in the world, behind the Chinese chain Mixue Ice Cream & Tea.
GEHC vs MCD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $5.1B | $7.0B |
| Net Profit | $411.0M | $2.2B |
| Gross Margin | 38.5% | — |
| Operating Margin | 10.0% | 45.0% |
| Net Margin | 8.0% | 30.9% |
| Revenue YoY | 7.4% | 9.7% |
| Net Profit YoY | -31.0% | 7.3% |
| EPS (diluted) | $0.85 | $3.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $5.1B | — | ||
| Q4 25 | $5.7B | $7.0B | ||
| Q3 25 | $5.1B | $7.1B | ||
| Q2 25 | $5.0B | $6.8B | ||
| Q1 25 | $4.8B | $6.0B | ||
| Q4 24 | $5.3B | $6.4B | ||
| Q3 24 | $4.9B | $6.9B | ||
| Q2 24 | $4.8B | $6.5B |
| Q1 26 | $411.0M | — | ||
| Q4 25 | $588.0M | $2.2B | ||
| Q3 25 | $446.0M | $2.3B | ||
| Q2 25 | $486.0M | $2.3B | ||
| Q1 25 | $564.0M | $1.9B | ||
| Q4 24 | $721.0M | $2.0B | ||
| Q3 24 | $470.0M | $2.3B | ||
| Q2 24 | $428.0M | $2.0B |
| Q1 26 | 38.5% | — | ||
| Q4 25 | 39.7% | — | ||
| Q3 25 | 38.7% | 90.6% | ||
| Q2 25 | 39.6% | 90.4% | ||
| Q1 25 | 42.1% | 89.6% | ||
| Q4 24 | 42.8% | — | ||
| Q3 24 | 41.7% | 90.6% | ||
| Q2 24 | 41.4% | 90.3% |
| Q1 26 | 10.0% | — | ||
| Q4 25 | 14.5% | 45.0% | ||
| Q3 25 | 12.7% | 47.4% | ||
| Q2 25 | 13.1% | 47.2% | ||
| Q1 25 | 13.2% | 44.5% | ||
| Q4 24 | 15.1% | 44.9% | ||
| Q3 24 | 13.9% | 46.4% | ||
| Q2 24 | 12.6% | 45.0% |
| Q1 26 | 8.0% | — | ||
| Q4 25 | 10.3% | 30.9% | ||
| Q3 25 | 8.7% | 32.2% | ||
| Q2 25 | 9.7% | 32.9% | ||
| Q1 25 | 11.8% | 31.4% | ||
| Q4 24 | 13.6% | 31.6% | ||
| Q3 24 | 9.7% | 32.8% | ||
| Q2 24 | 8.8% | 31.2% |
| Q1 26 | $0.85 | — | ||
| Q4 25 | $1.28 | $3.03 | ||
| Q3 25 | $0.98 | $3.18 | ||
| Q2 25 | $1.06 | $3.14 | ||
| Q1 25 | $1.23 | $2.60 | ||
| Q4 24 | $1.58 | $2.80 | ||
| Q3 24 | $1.02 | $3.13 | ||
| Q2 24 | $0.93 | $2.80 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $774.0M |
| Total DebtLower is stronger | $10.1B | $40.0B |
| Stockholders' EquityBook value | $10.7B | $-1.8B |
| Total Assets | $37.1B | $59.5B |
| Debt / EquityLower = less leverage | 0.95× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $4.5B | $774.0M | ||
| Q3 25 | $4.0B | $2.4B | ||
| Q2 25 | $3.7B | $1.9B | ||
| Q1 25 | $2.5B | $1.2B | ||
| Q4 24 | $2.9B | $1.1B | ||
| Q3 24 | $3.5B | $1.2B | ||
| Q2 24 | $2.0B | $792.0M |
| Q1 26 | $10.1B | — | ||
| Q4 25 | $10.0B | $40.0B | ||
| Q3 25 | $10.3B | — | ||
| Q2 25 | $10.3B | — | ||
| Q1 25 | $8.8B | — | ||
| Q4 24 | $9.0B | $38.4B | ||
| Q3 24 | $10.3B | — | ||
| Q2 24 | $9.2B | — |
| Q1 26 | $10.7B | — | ||
| Q4 25 | $10.4B | $-1.8B | ||
| Q3 25 | $10.0B | $-2.2B | ||
| Q2 25 | $9.7B | $-2.8B | ||
| Q1 25 | $9.2B | $-3.5B | ||
| Q4 24 | $8.4B | $-3.8B | ||
| Q3 24 | $8.3B | $-5.2B | ||
| Q2 24 | $7.8B | $-4.8B |
| Q1 26 | $37.1B | — | ||
| Q4 25 | $36.9B | $59.5B | ||
| Q3 25 | $36.1B | $60.6B | ||
| Q2 25 | $35.5B | $59.6B | ||
| Q1 25 | $33.6B | $56.3B | ||
| Q4 24 | $33.1B | $55.2B | ||
| Q3 24 | $33.9B | $56.2B | ||
| Q2 24 | $31.9B | $53.8B |
| Q1 26 | 0.95× | — | ||
| Q4 25 | 0.96× | — | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 1.06× | — | ||
| Q1 25 | 0.95× | — | ||
| Q4 24 | 1.06× | — | ||
| Q3 24 | 1.24× | — | ||
| Q2 24 | 1.18× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $2.7B |
| Free Cash FlowOCF − Capex | $112.0M | $1.6B |
| FCF MarginFCF / Revenue | 2.2% | 23.4% |
| Capex IntensityCapex / Revenue | — | 15.1% |
| Cash ConversionOCF / Net Profit | — | 1.25× |
| TTM Free Cash FlowTrailing 4 quarters | — | $7.2B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $2.7B | ||
| Q3 25 | — | $3.4B | ||
| Q2 25 | $94.0M | $2.0B | ||
| Q1 25 | $250.0M | $2.4B | ||
| Q4 24 | — | $2.6B | ||
| Q3 24 | — | $2.7B | ||
| Q2 24 | $-119.0M | $1.7B |
| Q1 26 | $112.0M | — | ||
| Q4 25 | — | $1.6B | ||
| Q3 25 | — | $2.4B | ||
| Q2 25 | $8.0M | $1.3B | ||
| Q1 25 | $98.0M | $1.9B | ||
| Q4 24 | — | $1.8B | ||
| Q3 24 | — | $1.9B | ||
| Q2 24 | $-183.0M | $1.1B |
| Q1 26 | 2.2% | — | ||
| Q4 25 | — | 23.4% | ||
| Q3 25 | — | 34.1% | ||
| Q2 25 | 0.2% | 18.3% | ||
| Q1 25 | 2.1% | 31.5% | ||
| Q4 24 | — | 28.6% | ||
| Q3 24 | — | 28.3% | ||
| Q2 24 | -3.8% | 16.3% |
| Q1 26 | — | — | ||
| Q4 25 | 2.4% | 15.1% | ||
| Q3 25 | 2.1% | 14.3% | ||
| Q2 25 | 1.7% | 10.9% | ||
| Q1 25 | 3.2% | 9.3% | ||
| Q4 24 | 1.9% | 12.6% | ||
| Q3 24 | 1.9% | 11.6% | ||
| Q2 24 | 1.3% | 9.7% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.25× | ||
| Q3 25 | — | 1.50× | ||
| Q2 25 | 0.19× | 0.89× | ||
| Q1 25 | 0.44× | 1.30× | ||
| Q4 24 | — | 1.30× | ||
| Q3 24 | — | 1.21× | ||
| Q2 24 | -0.28× | 0.84× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GEHC
| Imaging revenues | $2.3B | 45% |
| AVS revenues | $1.3B | 26% |
| PDx revenues | $770.0M | 15% |
| PCS revenues | $704.0M | 14% |
| Other revenues | $18.0M | 0% |
MCD
| International Operated Markets | $3.6B | 51% |
| Other | $2.8B | 40% |
| International Developmental Licensed Marketsand Corporate | $633.0M | 9% |
